Sharon Tetlow - 14 Sep 2021 Form 3 Insider Report for DICE Therapeutics, Inc.

Role
Director
Signature
/s/ Scott Robertson as attorney-in-fact for Sharon Tetlow
Issuer symbol
N/A
Transactions as of
14 Sep 2021
Net transactions value
$0
Form type
3
Filing time
14 Sep 2021, 19:27:08 UTC
Previous filing
02 Jul 2021
Next filing
08 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding DICE Common Stock 69,000 14 Sep 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Certain of the shares are subject to the Issuer's right of repurchase if underlying vesting conditions are not met.

Remarks:

Exhibit 24 - Power of Attorney